Granulocyte transfusions in children and young adults: does the dose matter?
about
Use of healthy-donor granulocyte transfusions to treat infections in neutropenic patients with myeloid or lymphoid neoplasms: experience in 74 patients treated with 373 granulocyte transfusions.Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia.Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversiesPolycythemia in an infant secondary to granulocyte transfusions.Granulocyte transfusions for children with infection and neutropenia or granulocyte dysfunction.Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia.Immunotherapy of Fungal Infections.Granulocyte transfusions in the management of invasive fungal infections.The anti-Aspergillus drug pipeline: Is the glass half full or empty?Characterization of buffy coat-derived granulocytes for clinical use: a comparison with granulocyte colony-stimulating factor/dexamethasone-pretreated donor-derived products.Granulocyte transfusions in critically ill children with prolonged neutropenia: side effects and survival rates from a single-center analysis.Experimental evidence that granulocyte transfusions are efficacious in treatment of neutropenic hosts with pulmonary aspergillosis.Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience.SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders.Granulocyte transfusions: A concise review for practitioners.
P2860
Q34456583-084374A8-4810-415E-95C1-DE041A1DB67EQ36093849-CFDCFBAD-1C2B-48A6-8217-E17410943B44Q36286585-B3495946-C7F1-4428-BC5C-82AEF0345907Q36599557-A9E9545A-EC94-4F19-A345-45F95F8850F3Q38175168-590CA362-409E-4571-8799-1B75D5F8F204Q38264086-254324F1-B69F-4804-B2C0-1BAE9F2CAD94Q38635409-B35C33CA-E9D1-4C6B-9B27-A23548561F16Q38907111-0E1F949B-F50E-4B59-8C57-3A62DD58E399Q38937577-7A0E6591-B997-4CF2-A7E1-FD309B79435AQ39000687-D5BE7120-51B2-482C-8E43-687AF3F227D4Q39387017-701393E2-3914-4AE3-A925-20E467262329Q39765887-CF9A2A75-1236-4FE0-A1D2-D5F532447DF5Q41371333-D04F9663-2528-4B97-B281-EAE38DFFC2D4Q47235713-E7224C0C-E06A-4455-9C67-3D8801B67707Q47976914-4199FE38-6D6B-441A-9B43-982B4E1E5946
P2860
Granulocyte transfusions in children and young adults: does the dose matter?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Granulocyte transfusions in children and young adults: does the dose matter?
@en
type
label
Granulocyte transfusions in children and young adults: does the dose matter?
@en
prefLabel
Granulocyte transfusions in children and young adults: does the dose matter?
@en
P2093
P50
P1476
Granulocyte transfusions in children and young adults: does the dose matter?
@en
P2093
Christina Peters
Gerda Leitner
Helmut Gadner
Nina Worel
Susanne Matthes-Martin
Volker Witt
P304
P356
10.1097/MPH.0B013E318196A6F9
P577
2009-03-01T00:00:00Z